José A Bauermeister1, Julie S Downs2, Douglas S Krakower3. 1. School of Nursing, University of Pennsylvania, 418 Curie Blvd, Room 222L, Philadelphia, PA, 19104, USA. bjose@upenn.edu. 2. Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, PA, USA. 3. Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Abstract
PURPOSE OF REVIEW: Advances in short- and long-acting pre-exposure prophylaxis (PrEP) technologies have incentivized the need to understand how individuals make trade-offs and competing decisions regarding PrEP modalities. The purpose of this review was to examine how researchers have conceptualized and measured attributes that are either intuitive and emotional (System 1) or deliberative and cognitive (System 2) in conjoint analysis or discrete choice experiments focused on diverse PrEP technologies among men who have sex with men (MSM). RECENT FINDINGS: Across the 9 studies meeting inclusion criteria, 5 included oral PrEP, 3 included topical rectal microbicides, 4 included PrEP injectables, and 1 study focused on an HIV prevention vaccine. Studies have not used uniform metrics, making comparisons difficult. Researchers measured attributes linked to System 2 processing (e.g., cost, efficacy), yet none examined System 1 processing. There is not one product or attribute preferable to all groups. Prevention products will need to be developed and promoted to reflect that diversity. Given that PrEP technologies have been solely informed by System 2 attributes, efforts to integrate System 1 attributes into ongoing and future PrEP choice experiments are pivotal to advance PrEP acceptability research and interventions to support their implementation.
PURPOSE OF REVIEW: Advances in short- and long-acting pre-exposure prophylaxis (PrEP) technologies have incentivized the need to understand how individuals make trade-offs and competing decisions regarding PrEP modalities. The purpose of this review was to examine how researchers have conceptualized and measured attributes that are either intuitive and emotional (System 1) or deliberative and cognitive (System 2) in conjoint analysis or discrete choice experiments focused on diverse PrEP technologies among men who have sex with men (MSM). RECENT FINDINGS: Across the 9 studies meeting inclusion criteria, 5 included oral PrEP, 3 included topical rectal microbicides, 4 included PrEP injectables, and 1 study focused on an HIV prevention vaccine. Studies have not used uniform metrics, making comparisons difficult. Researchers measured attributes linked to System 2 processing (e.g., cost, efficacy), yet none examined System 1 processing. There is not one product or attribute preferable to all groups. Prevention products will need to be developed and promoted to reflect that diversity. Given that PrEP technologies have been solely informed by System 2 attributes, efforts to integrate System 1 attributes into ongoing and future PrEP choice experiments are pivotal to advance PrEP acceptability research and interventions to support their implementation.
Entities:
Keywords:
Acceptability; Conjoint analysis; Decision-making; Discrete choice; Dual process
Authors: A Brett Hauber; Ateesha F Mohamed; Maria E Watson; F Reed Johnson; Jaime E Hernandez Journal: AIDS Patient Care STDS Date: 2009-01 Impact factor: 5.078
Authors: Aaron J Siegler; Anna Bratcher; Kevin M Weiss; Farah Mouhanna; Lauren Ahlschlager; Patrick S Sullivan Journal: Ann Epidemiol Date: 2018-05-26 Impact factor: 3.797
Authors: Robert C Bailey; Makobu Kimani; Rhoda Kabuti; Edwin Gumbe; George Otieno; Joshua Kimani; Duncan Okall; Eduard J Sanders; Fredrick O Otieno Journal: AIDS Behav Date: 2022-06-10
Authors: José A Bauermeister; Ryan C Tingler; Clara Dominguez; Eileen F Dunne; Craig Hoesley; Ken Ho; Sherri Johnson; Jonathan Lucas; Nicole Macagna; Elizabeth Brown; Holly Gundacker; Melissa Peda; Cindy E Jacobson; Lindsay Kramzer; Devika Singh; Charlene S Dezzutti; Ratiya Pamela Kunjara Na Ayudhya; Mark A Marzinke; Jeanna Piper; Bríd Devlin; Jeremy Nuttall; Ian McGowan; Craig W Hendrix; Ross D Cranston Journal: AIDS Behav Date: 2021-10-17
Authors: Katie B Biello; Pablo K Valente; Willey Y Lin; William Lodge Ii; Ryan Drab; Lisa Hightow-Weidman; Daniel Teixeira da Silva; Kenneth Mayer; José A Bauermeister Journal: AIDS Behav Date: 2021-12-03